Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Cancer Genes Hypermethylated in Human Embryonic Stem Cells

  • Vincenzo Calvanese,

    Affiliation Cancer Epigenetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

  • Angelica Horrillo,

    Affiliation Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER), Seville, Spain

  • Abdelkrim Hmadcha,

    Affiliation Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER), Seville, Spain

  • Beatriz Suarez-Álvarez,

    Affiliation Unidad de Histocompatibilidad, HUCA, Oviedo, Spain

  • Agustín F. Fernandez,

    Affiliations Cancer Epigenetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain, Cancer Epigenetics and Biology Program (PEBC), Catalan Institute of Oncology (ICO), Barcelona, Spain

  • Ester Lara,

    Affiliation Cancer Epigenetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

  • Sara Casado,

    Affiliation Cancer Epigenetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

  • Pablo Menendez,

    Affiliation Andalusian Stem Cell Bank (BACM)/University of Granada, Instituto de Investigaciones Biomédicas, Parque Tecnológico de la Salud, Granada, Spain

  • Clara Bueno,

    Affiliation Andalusian Stem Cell Bank (BACM)/University of Granada, Instituto de Investigaciones Biomédicas, Parque Tecnológico de la Salud, Granada, Spain

  • Javier Garcia-Castro,

    Affiliation Andalusian Stem Cell Bank (BACM)/University of Granada, Instituto de Investigaciones Biomédicas, Parque Tecnológico de la Salud, Granada, Spain

  • Ruth Rubio,

    Affiliation Andalusian Stem Cell Bank (BACM)/University of Granada, Instituto de Investigaciones Biomédicas, Parque Tecnológico de la Salud, Granada, Spain

  • Pablo Lapunzina,

    Affiliation S. de Genética Médica y Molecular, Hospital Universitario La Paz, Madrid y CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain

  • Miguel Alaminos,

    Affiliation Department of Histology, University of Granada, Granada, Spain

  • Lodovica Borghese,

    Affiliation Institute of Reconstructive Neurobiology, LIFE & BRAIN Center, University of Bonn and Hertie Foundation, Bonn, Germany

  • Stefanie Terstegge,

    Affiliation Institute of Reconstructive Neurobiology, LIFE & BRAIN Center, University of Bonn and Hertie Foundation, Bonn, Germany

  • Neil J. Harrison,

    Affiliation Centre for Stem Cell Biology and the Department of Biomedical Science, University of Sheffield, Sheffield, United Kingdom

  • Harry D. Moore,

    Affiliation Centre for Stem Cell Biology and the Department of Biomedical Science, University of Sheffield, Sheffield, United Kingdom

  • Oliver Brüstle,

    Affiliation Institute of Reconstructive Neurobiology, LIFE & BRAIN Center, University of Bonn and Hertie Foundation, Bonn, Germany

  • Carlos Lopez-Larrea,

    Affiliation Unidad de Histocompatibilidad, HUCA, Oviedo, Spain

  • Peter W. Andrews,

    Affiliation Centre for Stem Cell Biology and the Department of Biomedical Science, University of Sheffield, Sheffield, United Kingdom

  • Bernat Soria,

    Affiliation Unidad de Histocompatibilidad, HUCA, Oviedo, Spain

  • Manel Esteller ,

    mffraga@cnio.es (MFF); mesteller@cnio.es (ME)

    Affiliations Cancer Epigenetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain, Cancer Epigenetics and Biology Program (PEBC), Catalan Institute of Oncology (ICO), Barcelona, Spain

  •  [ ... ],
  • Mario F. Fraga

    mffraga@cnio.es (MFF); mesteller@cnio.es (ME)

    Affiliations Cancer Epigenetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain, Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Darwin 3, Cantoblanco, Madrid, Spain

  • [ view all ]
  • [ view less ]

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.